CA2942878C — Pharmaceutical liquid composition comprising sodium picosulfate, magnesium oxide, citric acid and malic acid
Assigned to Ferring International Center SA · Expires 2021-08-24 · 5y expired
What this patent protects
ABSTRACT The present invention relates to a pharmaceutical liquid composition, which is physically and chemically stable, comprising sodium picosulfate, magnesium oxide, citric acid and malic acid. The invention aims at reducing the amount of precipitation which may occur during …
USPTO Abstract
ABSTRACT The present invention relates to a pharmaceutical liquid composition, which is physically and chemically stable, comprising sodium picosulfate, magnesium oxide, citric acid and malic acid. The invention aims at reducing the amount of precipitation which may occur during storage of the pharmaceutical liquid composition. Date recue/Date Received 2020-11-30
Drugs covered by this patent
- Renacidin (CITRIC ACID) · Baxter
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.